// App-Quantinova.ai

: Brain regions with higher noradrenergic innervation show greater vulnerability to degeneration in preclinicial Alzheimer’s disease

Researchers

Presenter

  • Lena Haag

Principal Investigators

  • Gabriel Ziegler

  • Renat Yakupov

  • Michael T. Heneka

  • Michael Wagner

  • Oliver Peters

  • Josef Priller

  • Anja Schneider

  • Jens Wiltfang

  • Katharina Buerger

  • Robert Perneczky

  • Stefan Teipel

  • Christoph Laske

  • Annika Spottke

  • Klaus Fliessbach

  • Frank Jessen

  • Emrah Duzel

  • Matthew Betts

  • Dorothea Hämmerer

Medical Centers

  • Institute for Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University

  • Institute of Cognitive Neuroscience, University College, London, United Kingdom

  • German Center for Neurodegenarative Diseases (DZNE)

  • German Center for Neurodegenerative Diseases (DZNE), Bonn, Venusberg-Campus 1, 53127 Bonn, Germany

Locations

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Mild cognitive impairment

  • Alzheimer's disease

Biomarkers

  • Apolipoprotein E

  • Stearoyl-CoA desaturase

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved